Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark(Umeå University), Adalsteinn Gunnlaugsson(Lund University), L. Beckman(Sundsvall Municipality), Camilla Thellenberg‐Karlsson(Umeå University), Morten Høyer(Aarhus University Hospital), Magnus Lagerlund, Jon Kindblom(University of Gothenburg), Claes Ginman(Karlstad Central Hospital), Bengt Johansson(Örebro University Hospital), Kirsten Björnlinger(Ryhov Hospital Jönköping), M. Seke(Centrallasarettet Växjö), Måns Agrup(Linköping University Hospital), Per Fransson(Umeå University), Björn Tavelin(Umeå University), David Norman(Umeå University), Björn Zackrisson(Umeå University), Harald Anderson(Lund University), Elisabeth Kjellén(Lund University), Lars Franzén(Umeå University), Per Nilsson(Skåne University Hospital)
The Lancet
June 18, 2019
Cited by 869

Abstract


Related Papers

No related papers found

Powered by citation graph analysis